ABBV vs PAYX · P/E 81, rev $16.99B vs P/E 22, rev $6.51B
AbbVie Inc (ABBV) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the ABBV and PAYX stock pages for the full models.
Not investment advice.